Navigation Links
BioRestorative Therapies Provides Company Updates with Shareholder Letter
Date:8/1/2013

Vienna, Austria. Mr. Silva presented the Company's research on Human Metabolically Active Brown Adipose Tissue Derived Stem Cells. This research is a result of the scientific work the Company has been performing pursuant to its ThermoStem® Program.  
  • The Company hired ProActive Capital in mid-April to help increase awareness of the Company among the investment community.  ProActive Capital is also helping to increase exposure through the use of social and digital media.
  • In mid April, the Company implemented a 1-for-50 reverse stock split which reduced its outstanding shares from 820,641,011 to 16,412,820. 94% of the shares voted were in favor of the proposal. The Company believes the reverse split will help attract a new base of shareholders as well as new institutional and retail support in the market.
  • In mid May, the Company signed an agreement with Dexterity, Inc., a product design and bioengineering firm, to further the development and production of its brtxDISC™ (Disc Implanted Stem Cells) stem cell therapy device.  This device plays an integral role in delivering stem cells for its proprietary bulging/herniated disc therapy.
  • In May, the Company once again presented its investment thesis at the Marcum MicroCap Conference.  To listen to the webcast, please visit http://wsw.com/webcast/marcum/brtx. The event hosted nearly 100 publicly traded companies with capitalizations under $500 million and attracted more than 1,000 people, including senior personnel from the presenting public companies, leading institutional investors, directors, bankers and service providers to the microcap marketplace.
  • At the end of May, the Company formally launched its "brtx-C Cosmetic" Program. The Company announced that it has developed a human cellular-derived extract that, per initial in v
    '/>"/>

  • SOURCE BioRestorative Therapies, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. BioRestorative Therapies Signs Material Manufacturing Agreement With University of Utah
    2. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
    3. BioRestorative Therapies Retains KCSA Strategic Communications as Investor Relations Counsel
    4. BioRestorative Therapies Obtains $2.1 Million in 2012 Private Financing
    5. BioRestorative Therapies Announces Closing of License Agreement for Adult Stem Cell Disc/Spine Procedure
    6. BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device
    7. BioRestorative Therapies Enters Into Brown Fat Research Agreement With University of Utah
    8. BioRestorative Therapies Announces Stock Trading On OTC Bulletin Board
    9. BioRestorative Therapies Announces Launch of New Website
    10. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
    11. BioRestorative Therapies Announces the Development of an Extract that has Promise for Use in Beauty Care Products
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/22/2014)... Respiratory therapy students will soon ... of life-like respiratory ailments using the latest in ... Rapids-based, Michigan Instruments Inc. developers of the world-renowned ... respiratory simulation units to the pro-gram, which cost ... Muskegon Community College are collaborating to offer Muskegon’s ...
    (Date:11/21/2014)... TRU-D SmartUVC LLC and its UK partners, Rapid Disinfection ... TRU-D SmartUVC, at FIS 2014 in Harrogate, England ... Stand 23. The conference, hosted by Federation of ... largest infection-related event of its kind and brings together more ... events of its type throughout the world. This annual event ...
    (Date:11/21/2014)... 20, 2014 The California ... research organization representing leading California academic institutions, biotechnology, ... PwC US today released a report revealing ... industry growth. The trend shows a 4 percent ... California Biomedical Industry Report indicates that, while ...
    (Date:11/21/2014)... 21, 2014 Why did Stephen Hawking ... Einstein so instantly recognizable? Why have they become icons ... and author Hilton Ratcliffe seeks out the answers to ... all to do with science. In " Stephen Hawking ... November 21, 2014), Ratcliffe puts it plainly: , ...
    Breaking Biology Technology:Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 2Michigan Instruments Donates Two Respiratory Simulation Training and Test Lung (TTL) Devices to Grand Valley State University 3TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 2TRU-D SmartUVC to Showcase Superbug-Killing Robot at FIS 2014 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 2“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 3“Stephen Hawking Smoked My Socks” Sparks Controversy in Science World 4
    ... the Predictable Relief Provided by the Only Commercially Available ... ... in Adults, DEERFIELD, Ill., Nov. 6 Takeda Pharmaceuticals ... the first direct-to-consumer (DTC) advertising campaign for AMITIZA(R),(lubiprostone), the only ...
    ... HORSHAM, Pa. and KENILWORTH, N.J., Nov. 6 ... Pharma Corporation,announced today that an estimated one ... (infliximab), the leading anti-tumor necrosis,factor (TNF)-alpha therapy ... to,treat more patients worldwide than all other ...
    ... and VALAIS, Switzerland, Nov. 5 ,Lantibio, Inc. and TRB ... a subsidiary of Alcon, Inc. (NYSE: ACL ) ... Eye Syndrome product. The,product consists of a TRB patented ... the US under an IND by a,subsidiary of Lantibio. ...
    Cached Biology Technology:'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down 2'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down 3'Move to AMITIZA' Advertising Campaign Underscores the Power of Not Letting Chronic Constipation Slow People Down 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 2REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 3REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 4REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 5REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 6REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 7REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 8REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 9REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 10REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 11REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide 12Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 2Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 3Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug 4
    (Date:11/4/2014)... newly published research study examining only marketing directed ... fast food restaurants has found that the majority ... exposed to such marketing tactics. , Authored by ... colleagues, the study is the first to examine ... and exterior of fast food restaurants and its ...
    (Date:11/4/2014)... 2014   Neurotechnology , a provider of ... latest version of its fingerprint matching algorithm has ... evaluation organized by NIST. The MINEX test ... INCITS 378 fingerprint standard template format. MINEX compliance ... in the United States ...
    (Date:11/3/2014)... 2014  NeuroSigma ® , Inc. (NeuroSigma), a ... focused on commercialization of its non-invasive ... of neurological and neuropsychiatric disorders, announced today that ... a Notice of Allowance for Mexican Patent Application ... NeuroSigma and the Regents of the University of ...
    Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 2NeuroSigma Receives Notice of Allowance from the Mexican Institute of Industrial Property Covering Subcutaneous Trigeminal Nerve Stimulation (sTNS) 3
    ... the University of Saskatchewan has discovered a signaling pathway in ... for blocking its action, that may point to a single ... the March issue of the prestigious journal Nature Medicine. , ... U of S department of psychiatry, found that a naturally ...
    ... the Forsyth Institute have discovered a new mechanism responsible ... locate themselves on the left or right side of ... mechanism, garnered through the study of three different vertebrates ... a single common mechanism has been identified in left-right ...
    ... Scientists generally agree that all cloned animals are biologically ... for stem cells derived from cloned embryos, the basis ... cell nuclear transfer, therapeutic cloning is a promising approach ... disorders. Demonstrated in mice but not in humans, it ...
    Cached Biology News:Team discovers possible 'universal strategy' to combat addiction 2Forsyth scientists gain greater understanding of how embryos differentiate left from right 2Forsyth scientists gain greater understanding of how embryos differentiate left from right 3Cloned stem cells prove identical to fertilized stem cells 2Cloned stem cells prove identical to fertilized stem cells 3
    Mouse monoclonal [SH-A1] to S100 alpha ( Abpromise for all tested applications). entrezGeneID: 6271 SwissProtID: P23297...
    Acid phosphatase (Potato). Monospecific by IEP. Some cross reactivity between Acid phosphatases of other species may occur....
    Latanoprost EIA Antiserum EIAs neutrophils antisera enzyme immunoassays reagents...
    Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
    Biology Products: